3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Colorectal Neoplasms
8
Stomach Neoplasms
3
Rectal Neoplasms
3
Neoplasms
3
Colonic Neoplasms
3
Carcinoma, Hepatocellular
3
Prostatic Neoplasms
2
Pancreatic cancer, adult
2
Lung Neoplasms
2
Recurrence
1
Pancreatic carcinoma, familial
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Obesity
1
Non-alcoholic Fatty Liver Disease
1
Neoplastic Cells, Circulating
1
Neoplasm Metastasis
1
Metabolic Syndrome
1
Liver Cirrhosis
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia
1
Glioblastoma
1
Fibrosis
1
Fatigue
1
Esophageal Neoplasms
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Barrett Esophagus
1
Adenocarcinoma Of Esophagus
1
Interventions
Bevacizumab
6
Nivolumab
5
pembrolizumab
4
Gemcitabine
4
Cisplatin
3
regorafenib
2
fludarabine
2
Sorafenib
2
Paclitaxel
2
Oxaliplatin
2
Leucovorin
2
Irinotecan
2
Fluorouracil
2
Drug Therapy
2
Cyclophosphamide
2
Azacitidine
2
vocimagene amiretrorepvec
1
ulixertinib
1
temsirolimus
1
spartalizumab
1
sonidegib
1
selinexor
1
sargramostim
1
sacituzumab govitecan
1
ruxolitinib
1
rucaparib
1
pazopanib
1
olutasidenib
1
olaparib
1
motexafin gadolinium
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Glioblastoma
×
Hematologic Tests
×
Gastrointestinal
×
Clear all
NCT06717295
2026-01-02
CCANED-CIPHER
Dysplasia Diagnostics Limited
Recruiting
6,000 enrolled